Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Gynecol Oncol. 2020 Aug;158(2):287-293. doi: 10.1016/j.ygyno.2020.05.004. Epub 2020 May 26.
Paraaortic lymph node involvement is an important prognostic factor in locally advanced cervical cancer (LACC), but the anatomic limit of aortic lymphadenectomy is controversial. We assessed the impact of extraperitoneal paraaortic lymphadenectomy up to the left renal vein in patients with LACC undergoing pretherapeutic staging.
A retrospective, multicenter study of patients with LACC stages FIGO 2009 IB2 and IIA2-IVA treated in 10 Spanish reference hospitals in gynecological oncology between 2000 and 2016. Sites of metastatic paraaortic lymph nodes above or below the inferior mesenteric artery were evaluated. Procedural-related intraoperative and early and late complications were assessed.
We included 634 patients undergoing paraaortic lymphadenectomy, in 616 (97.2%) of which the left renal vein was the upper limit of dissection (laparoscopy 592, robotic-assisted 24). The median surgical time was 150 min (interquartile range (IQR) 120-180), blood loss was 50 mL (range 20-80), and the length of stay was 2 days (range 2-3). Metastatic paraaortic involvement was found in 114 patients (18.5%), with infrarenal metastases in 73 (64%) of them. There were 11 patients (9.6%) with infrarenal metastases only, whereas in the remaining 62 (54.4%) patients concomitant infrarenal and inframesenteric metastases were observed. Intraoperative, early, and late postoperative complications occurred in 3.6%, 7.0%, and 4.5% of patients, respectively.
In this study of patients with LACC undergoing surgical staging, paraaortic lymphadenectomy up to the left renal vein detected skip or isolated infrarenal metastasis in 9.6% of patients, with an acceptable surgical morbidity.
在局部晚期宫颈癌(LACC)中,腹主动脉旁淋巴结受累是一个重要的预后因素,但主动脉旁淋巴结清扫的解剖学界限仍存在争议。我们评估了在接受治疗前分期的 LACC 患者中进行腹膜外腹主动脉旁淋巴结清扫至左肾静脉的影响。
这是一项回顾性、多中心研究,纳入了 2000 年至 2016 年期间在西班牙 10 家妇科肿瘤学参考医院接受治疗的 LACC 分期为 FIGO 2009 IB2 和 IIA2-IVA 的患者。评估肠系膜下动脉上方或下方转移性腹主动脉旁淋巴结的部位。评估与手术相关的术中、早期和晚期并发症。
我们纳入了 634 例行腹主动脉旁淋巴结清扫术的患者,其中 616 例(97.2%)的左肾静脉为清扫的上限(腹腔镜 592 例,机器人辅助 24 例)。中位手术时间为 150 分钟(四分位间距(IQR)120-180),术中出血量为 50 毫升(范围 20-80),住院时间为 2 天(范围 2-3)。114 例(18.5%)患者发现腹主动脉旁转移,其中 73 例(64%)为肾下转移。有 11 例(9.6%)患者仅存在肾下转移,而在其余 62 例(54.4%)患者中观察到同时存在肾下和肠系膜下转移。术中、早期和晚期术后并发症的发生率分别为 3.6%、7.0%和 4.5%。
在这项接受手术分期的 LACC 患者研究中,腹主动脉旁淋巴结清扫至左肾静脉检测到 9.6%的患者存在跳跃或孤立的肾下转移,手术发病率可接受。